{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:19:45Z","timestamp":1794892785659,"version":"4.9.1"},"reference-count":122,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T00:00:00Z","timestamp":1623542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The prostaglandins constitute a family of lipids of 20 carbon atoms that derive from polyunsaturated fatty acids such as arachidonic acid. Traditionally, prostaglandins have been linked to inflammation, female reproductive cycle, vasodilation, or bronchodilator\/bronchoconstriction. Recent studies have highlighted the involvement of these lipids in cancer. In this review, existing information on the prostaglandins associated with different types of cancer and the advances related to the potential use of them in neoplasm therapies have been analyzed. We can conclude that the effect of prostaglandins depends on multiple factors, such as the target tissue, their plasma concentration, and the prostaglandin subtype, among others. Prostaglandin D2 (PGD2) seems to hinder tumor progression, while prostaglandin E2 (PGE2) and prostaglandin F2 alpha (PGF2\u03b1) seem to provide greater tumor progression and aggressiveness. However, more studies are needed to determine the role of prostaglandin I2 (PGI2) and prostaglandin J2 (PGJ2) in cancer due to the conflicting data obtained. On the other hand, the use of different NSAIDs (non-steroidal anti-inflammatory drugs), especially those selective of COX-2 (cyclooxygenase 2), could have a crucial role in the fight against different neoplasms, either as prophylaxis or as an adjuvant treatment. In addition, multiple targets, related to the action of prostaglandins on the intracellular signaling pathways that are involved in cancer, have been discovered. Thus, in depth research about the prostaglandins involved in different cancer and the different targets modulated by them, as well as their role in the tumor microenvironment and the immune response, is necessary to obtain better therapeutic tools to fight cancer.<\/jats:p>","DOI":"10.3390\/cells10061487","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T10:30:25Z","timestamp":1623666625000},"page":"1487","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["The Role of Prostaglandins in Different Types of Cancer"],"prefix":"10.3390","volume":"10","author":[{"given":"\u00c1lvaro","family":"Jara-Guti\u00e9rrez","sequence":"first","affiliation":[{"name":"\u00c1rea de Bioqu\u00edmica y Biolog\u00eda Molecular, Departamento de Qu\u00edmica Inorg\u00e1nica, Org\u00e1nica y Bioqu\u00edmica, Facultad de Medicina de Albacete\/CRIB\/Unidad de Biomedicina, Universidad de Castilla-La Mancha\/CSIC, C\/Almansa 14, 02008 Albacete, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4574-8760","authenticated-orcid":false,"given":"Victoriano","family":"Baladr\u00f3n","sequence":"additional","affiliation":[{"name":"\u00c1rea de Bioqu\u00edmica y Biolog\u00eda Molecular, Departamento de Qu\u00edmica Inorg\u00e1nica, Org\u00e1nica y Bioqu\u00edmica, Facultad de Medicina de Albacete\/CRIB\/Unidad de Biomedicina, Universidad de Castilla-La Mancha\/CSIC, C\/Almansa 14, 02008 Albacete, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3181\/00379727-28-5265","article-title":"Biochemical Studies of Human Semen. II. The Action of Semen on the Human Uterus","volume":"28","year":"1930","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e13098","DOI":"10.1111\/apha.13098","article-title":"Remembrances of Ulf Svante von Euler","volume":"224","author":"Igic","year":"2018","journal-title":"Acta Physiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1748-1716.1959.tb01686.x","article-title":"Observations on the effects of infusion of prostaglandin E in man","volume":"45","author":"Bergstrom","year":"1959","journal-title":"Acta Physiol. Scand."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/212038a0","article-title":"Absolute configuration of the prostaglandins","volume":"212","author":"Nugteren","year":"1966","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat New Biol."},{"key":"ref_6","first-page":"61","article-title":"The prostaglandins","volume":"29","author":"Nagy","year":"1981","journal-title":"Ther. Hung."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/0310057X7500300204","article-title":"Prostaglandins\u2014A review","volume":"3","author":"Holdcroft","year":"1975","journal-title":"Anaesth. Intensive Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/EBC20190083","article-title":"Eicosanoids","volume":"64","author":"Calder","year":"2020","journal-title":"Essays Biochem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/jm00255a001","article-title":"Prostaglandin nomenclature","volume":"17","author":"Nelson","year":"1974","journal-title":"J. Med. Chem."},{"key":"ref_10","first-page":"15","article-title":"COX-1 and COX-2 tissue expression: Implications and predictions","volume":"49","author":"Crofford","year":"1997","journal-title":"J. Rheumatol. Suppl."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: Structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7908","DOI":"10.1038\/sj.onc.1203286","article-title":"The role of cyclooxygenases in inflammation, cancer, and development","volume":"18","author":"Williams","year":"1999","journal-title":"Oncogene"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1007\/s000110050284","article-title":"Anti-inflammatory drugs and their mechanism of action","volume":"47","author":"Vane","year":"1998","journal-title":"Inflamm. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14656566.2.1.1","article-title":"Anti-inflammatory drugs, cyclooxygenases and other factors","volume":"2","author":"Bennett","year":"2001","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1358\/dot.1999.35.4-5.552199","article-title":"Nonsteroidal antiinflammatory agents","volume":"35","author":"Botting","year":"1999","journal-title":"Drugs Today"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0223-5234(01)01197-7","article-title":"Cyclooxygenase inhibitors\u2014Current status and future prospects","volume":"36","author":"Dannhardt","year":"2001","journal-title":"Eur. J. Med. Chem."},{"key":"ref_18","first-page":"515","article-title":"Cyclooxygenase inhibitors","volume":"30","author":"Eschwege","year":"2001","journal-title":"Presse Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase isozymes: The biology of prostaglandin synthesis and inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S1357-2725(98)00152-6","article-title":"Cyclooxygenase-1 and -2 isoenzymes","volume":"31","author":"Hla","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10555-010-9264-x","article-title":"Cytochrome P450-derived eicosanoids: The neglected pathway in cancer","volume":"29","author":"Panigrahy","year":"2010","journal-title":"Cancer Metastasis Rev."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wang, T., Fu, X., Chen, Q., Patra, J.K., Wang, D., Wang, Z., and Gai, Z. (2019). Arachidonic Acid Metabolism and Kidney Inflammation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153683"},{"key":"ref_23","first-page":"9175","article-title":"Prostaglandin transporter, SLCO2A1, mediates the invasion and apoptosis of lung cancer cells via PI3K\/AKT\/mTOR pathway","volume":"8","author":"Zhu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/0006-291X(91)90677-Y","article-title":"Regulation of synthesis and activity of NAD(+)-dependent 15-hydroxy-prostaglandin dehydrogenase (15-PGDH) by dexamethasone and phorbol ester in human erythroleukemia (HEL) cells","volume":"177","author":"Xun","year":"1991","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2016.12.004","article-title":"Eicosanoid receptors: Targets for the treatment of disrupted intestinal epithelial homeostasis","volume":"796","author":"Moreno","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"16104","DOI":"10.1073\/pnas.1107533108","article-title":"Prostaglandin E2 release from astrocytes triggers gonadotropin-releasing hormone (GnRH) neuron firing via EP2 receptor activation","volume":"108","author":"Clasadonte","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","first-page":"359","article-title":"Functions of prostaglandins","volume":"2","author":"Jones","year":"1972","journal-title":"Pathobiol. Annu."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0952-3278(96)90064-2","article-title":"Prostaglandins, their inhibitors and cancer","volume":"54","author":"Lupulescu","year":"1996","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"ref_29","first-page":"1025","article-title":"An update on eicosanoids and inhibitors of cyclooxygenase enzyme systems","volume":"35","author":"Sharma","year":"1997","journal-title":"Indian J. Exp. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1742-7843.2008.00332.x","article-title":"Effects of nimesulide, acetylsalicylic acid, ibuprofen and nabumetone on cyclooxygenase-1- and cyclooxygenase-2-mediated prostanoid production in healthy volunteers ex vivo","volume":"104","author":"Kerola","year":"2009","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11916-013-0327-x","article-title":"Mechanism of action of indomethacin in indomethacin-responsive headaches","volume":"17","author":"Summ","year":"2013","journal-title":"Curr. Pain Headache Rep."},{"key":"ref_32","first-page":"655","article-title":"Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships","volume":"10","author":"Zarghi","year":"2011","journal-title":"Iran. J. Pharm. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/exd.12576","article-title":"A new target for squamous cell skin cancer?","volume":"24","author":"Kim","year":"2015","journal-title":"Exp. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"486","DOI":"10.7150\/thno.22059","article-title":"MiR-31-5p-ACOX1 Axis Enhances Tumorigenic Fitness in Oral Squamous Cell Carcinoma Via the Promigratory Prostaglandin E2","volume":"8","author":"Lai","year":"2018","journal-title":"Theranostics"},{"key":"ref_35","first-page":"648","article-title":"15d-PGJ2 is a new hope for controlling tumor growth","volume":"10","author":"Bie","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e530s","DOI":"10.6061\/clinics\/2018\/e530s","article-title":"Eicosanoids and cancer","volume":"73","author":"Gomes","year":"2018","journal-title":"Clinics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.plefa.2015.11.006","article-title":"Apigenin inhibits COX-2, PGE2, and EP1 and also initiates terminal differentiation in the epidermis of tumor bearing mice","volume":"104","author":"Kiraly","year":"2016","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.2147\/DDDT.S84849","article-title":"The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors","volume":"9","author":"Campione","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"49959","DOI":"10.18632\/oncotarget.18326","article-title":"Acetylsalicylic acid inhibits the growth of melanoma tumors via SOX2-dependent-PAF-R-independent signaling pathway","volume":"8","author":"Thyagarajan","year":"2017","journal-title":"Oncotarget"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Wu, J.C., Tsai, H.E., Hsiao, Y.H., Wu, J.S., Wu, C.S., and Tai, M.H. (2020). Topical MTII Therapy Suppresses Melanoma through PTEN Upregulation and Cyclooxygenase II Inhibition. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020681"},{"key":"ref_41","first-page":"579","article-title":"SND1 promotes the proliferation of osteosarcoma cells by upregulating COX2\/PGE2 expression via activation of NF-\u03baB","volume":"41","author":"Zhou","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_42","first-page":"265","article-title":"EP1 receptor is involved in prostaglandin E2-induced osteosarcoma growth","volume":"19","author":"Niu","year":"2019","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1159\/000509671","article-title":"Evaluation of the Diagnostic and Predicative Values of 8-Iso-Prostaglandin F2\u03b1 as a Biomarker of Breast Cancer","volume":"43","author":"Mirza","year":"2020","journal-title":"Oncol. Res. Treat."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/CEJ.0000000000000098","article-title":"Aspirin and NSAIDs for breast cancer chemoprevention","volume":"24","author":"Yiannakopoulou","year":"2015","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.mce.2015.07.008","article-title":"11\u03b2-Prostaglandin F2\u03b1, a bioactive metabolite catalyzed by AKR1C3, stimulates prostaglandin F receptor and induces slug expression in breast cancer","volume":"413","author":"Yoda","year":"2015","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.canlet.2018.03.016","article-title":"15-Deoxy-Delta(12,14)-prostaglandin J2 activates PI3K-Akt signaling in human breast cancer cells through covalent modification of the tumor suppressor PTEN at cysteine 136","volume":"424","author":"Suh","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"10284","DOI":"10.18632\/oncotarget.3581","article-title":"MPGES-1-derived PGE2 suppresses CD80 expression on tumor-associated phagocytes to inhibit anti-tumor immune responses in breast cancer","volume":"6","author":"Olesch","year":"2015","journal-title":"Oncotarget"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s40425-018-0406-y","article-title":"Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer","volume":"6","author":"Pennock","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1158\/1078-0432.CCR-17-0152","article-title":"Perioperative COX-2 and \u03b2-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial","volume":"23","author":"Shaashua","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"152","DOI":"10.15430\/JCP.2020.25.3.152","article-title":"15-Deoxy-Delta(12,14)-prostaglandin J2 Induces Epithelial-to-mesenchymal Transition in Human Breast Cancer Cells and Promotes Fibroblast Activation","volume":"25","author":"Choi","year":"2020","journal-title":"J. Cancer Prev."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"De Paz Linares, G.A., Opperman, R.M., Majumder, M., and Lala, P.K. (2021). Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis. Cancers, 13.","DOI":"10.3390\/cancers13050942"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1038\/s41388-020-1196-5","article-title":"The ACSL3-LPIAT1 signaling drives prostaglandin synthesis in non-small cell lung cancer","volume":"39","author":"Saliakoura","year":"2020","journal-title":"Oncogene"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4149\/neo_2020_190526N463","article-title":"Combined PGE2 with TNF-\u03b1 promotes laryngeal carcinoma progression by enhancing GRK2 and TRAF2 interaction","volume":"67","author":"Li","year":"2020","journal-title":"Neoplasma"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/jnci\/dju358","article-title":"Role of LKB1-CRTC1 on glycosylated COX-2 and response to COX-2 inhibition in lung cancer","volume":"107","author":"Cao","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"6933","DOI":"10.1096\/fj.201802547R","article-title":"miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction","volume":"33","author":"Saul","year":"2019","journal-title":"FASEB J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e1423182","DOI":"10.1080\/2162402X.2017.1423182","article-title":"Targeted overexpression of prostacyclin synthase inhibits lung tumor progression by recruiting CD4+ T lymphocytes in tumors that express MHC class II","volume":"7","author":"Li","year":"2018","journal-title":"Oncoimmunology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ejca.2015.02.004","article-title":"Distinct effects of anti-inflammatory and anti-thrombotic drugs on cancer characteristics at diagnosis","volume":"51","author":"Pawitan","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1525-7304(11)70183-8","article-title":"Cyclooxygenase-2 inhibitors as chemopreventive agents in lung cancer","volume":"5","author":"Price","year":"2004","journal-title":"Clin. Lung Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"8866","DOI":"10.18632\/oncotarget.6839","article-title":"Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2","volume":"7","author":"Xu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.3748\/wjg.v23.i20.3572","article-title":"Cyclooxygenase 2 in liver dysfunction and carcinogenesis: Facts and perspectives","volume":"23","author":"Casado","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e001377","DOI":"10.1136\/jitc-2020-001377","article-title":"2,5-dimethylcelecoxib improves immune microenvironment of hepatocellular carcinoma by promoting ubiquitination of HBx-induced PD-L1","volume":"8","author":"Chen","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/cncr.32010","article-title":"Cyclooxygenase-2 in gastrointestinal malignancies","volume":"125","author":"Nagaraju","year":"2019","journal-title":"Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7419","DOI":"10.2147\/CMAR.S245726","article-title":"15-PGDH Expression in Gastric Cancer: A Potential Role in Anti-Tumor Immunity","volume":"12","author":"Li","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2741\/4914","article-title":"Role of Cyclooxygenase-2 in colorectal cancer patients","volume":"26","author":"Nanda","year":"2021","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1038\/onc.2015.283","article-title":"Dysregulated CRTC1 activity is a novel component of PGE2 signaling that contributes to colon cancer growth","volume":"35","author":"Schumacher","year":"2016","journal-title":"Oncogene"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Zheng, F., Yu, Z., Hao, J., Chen, M., Yu, W., Guo, W., Chen, Y., Huang, W., and Duan, Z. (2017). XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186900"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.critrevonc.2016.05.011","article-title":"The role of aspirin in colorectal cancer chemoprevention","volume":"104","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1194\/jlr.M078725","article-title":"Aspirin alone and combined with a statin suppresses eicosanoid formation in human colon tissue","volume":"59","author":"Gottschall","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/carcin\/bgu241","article-title":"Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs","volume":"36","author":"Fink","year":"2015","journal-title":"Carcinogenesis"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.prostaglandins.2017.08.002","article-title":"Modulating effect of inositol hexaphosphate on arachidonic acid-dependent pathways in colon cancer cells","volume":"131","author":"Kapral","year":"2017","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"C639","DOI":"10.1152\/ajpcell.00417.2014","article-title":"Prostaglandin E2 activates the mTORC1 pathway through an EP4\/cAMP\/PKA- and EP1\/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1","volume":"309","author":"Chang","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"39941","DOI":"10.18632\/oncotarget.5402","article-title":"Prostaglandins induce early growth response 1 transcription factor mediated microsomal prostaglandin E2 synthase up-regulation for colorectal cancer progression","volume":"6","author":"Stamatakis","year":"2015","journal-title":"Oncotarget"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.7150\/jca.16244","article-title":"Role of Urinary Biomarkers in the Diagnosis of Adenoma and Colorectal Cancer: A Systematic Review and Meta-Analysis","volume":"7","author":"Altobelli","year":"2016","journal-title":"J. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Mizuno, R., Kawada, K., and Sakai, Y. (2019). Prostaglandin E2\/EP Signaling in the Tumor Microenvironment of Colorectal Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20246254"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"17444","DOI":"10.1038\/s41598-020-74368-3","article-title":"The vitamin D analogue calcipotriol promotes an anti-tumorigenic phenotype of human pancreatic CAFs but reduces T cell mediated immunity","volume":"10","author":"Gorchs","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"111480","DOI":"10.1016\/j.ecoenv.2020.111480","article-title":"Cadmium induces epithelial-mesenchymal transition and migration of renal cancer cells by increasing PGE2 through a cAMP\/PKA-COX2 dependent mechanism","volume":"207","author":"Shi","year":"2021","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.prostaglandins.2019.02.004","article-title":"Physiological and pathological levels of prostaglandin E2 in renal parenchyma and neoplastic renal tissue","volume":"141","author":"Verratti","year":"2019","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"106409","DOI":"10.1016\/j.prostaglandins.2020.106409","article-title":"Prostaglandin E2 as a therapeutic target in bladder cancer: From basic science to clinical trials","volume":"148","author":"Woolbright","year":"2020","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-030-21735-8_9","article-title":"Targeting the COX\/mPGES-1\/PGE2 Pathway in Neuroblastoma","volume":"1161","author":"Larsson","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"15459","DOI":"10.1002\/jcp.28194","article-title":"Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation","volume":"9","author":"Pozzoli","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biopha.2018.06.099","article-title":"The down-regulation of microRNA-137 contributes to the up-regulation of retinoblastoma cell proliferation and invasion by regulating COX-2\/PGE2 signaling","volume":"106","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.biocel.2017.05.022","article-title":"Cell biology-metabolic crosstalk in glioma","volume":"89","author":"Colquhoun","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/jnc.13503","article-title":"Tryptophan-2,3-dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor-4","volume":"136","author":"Ochs","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.imlet.2017.01.019","article-title":"COX-2 inhibitor prevents tumor induced down regulation of classical DC lineage specific transcription factor Zbtb46 resulting in immunocompetent DC and decreased tumor burden","volume":"184","author":"Pandey","year":"2017","journal-title":"Immunol. Lett."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.yexmp.2017.05.003","article-title":"15d-PGJ2 as an endoplasmic reticulum stress manipulator in multiple myeloma in vitro and in vivo","volume":"102","author":"Sperandio","year":"2017","journal-title":"Exp. Mol. Pathol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1182\/bloodadvances.2019000473","article-title":"Targeting cyclooxygenase by indomethacin decelerates progression of acute lymphoblastic leukemia in a xenograft model","volume":"3","author":"Richartz","year":"2019","journal-title":"Blood Adv."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/blood.2020005712","article-title":"Prostaglandin E2 stimulates cAMP signaling and resensitizes human leukemia cells to glucocorticoid-induced cell death","volume":"137","author":"Roderick","year":"2021","journal-title":"Blood"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1182\/blood-2016-08-736405","article-title":"Activation of PPARgamma by endogenous prostaglandin J2 mediates the antileukemic effect of selenium in murine leukemia","volume":"129","author":"Finch","year":"2017","journal-title":"Blood"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Akbari, N., Ghorbani, M., Salimi, V., Alimohammadi, A., Khamseh, M.E., Akbari, H., Nourbakhsh, M., Sheikhi, A., Taghavi, S.F., and Tavakoli-Yaraki, M. (2020). Cyclooxygenase enzyme and PGE2 expression in patients with functional and non-functional pituitary adenomas. BMC Endocr. Disord., 20.","DOI":"10.1186\/s12902-020-0515-8"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Parvathareddy, S.K., Siraj, A.K., Annaiyappanaidu, P., Al-Sobhi, S.S., Al-Dayel, F., and Al-Kuraya, K.S. (2020). Prognostic Significance of COX-2 Overexpression in BRAF-Mutated Middle Eastern Papillary Thyroid Carcinoma. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249498"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mce.2018.07.002","article-title":"AKR1C3 (type 5 17\u03b2-hydroxysteroid dehydrogenase\/prostaglandin F synthase): Roles in malignancy and endocrine disorders","volume":"489","author":"Penning","year":"2019","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"48050","DOI":"10.18632\/oncotarget.10347","article-title":"Overexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiation","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10555-018-9750-0","article-title":"Eicosanoids in prostate cancer","volume":"37","author":"Panagiotopoulos","year":"2018","journal-title":"Cancer Metastasis Rev."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1038\/onc.2017.82","article-title":"Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis","volume":"36","author":"Ko","year":"2017","journal-title":"Oncogene"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s12253-018-0534-1","article-title":"Prognostic and Clinic-Pathological Significances of SCF and COX-2 Expression in Inflammatory and Malignant Prostatic Lesions","volume":"25","author":"Alabiad","year":"2019","journal-title":"Pathol. Oncol. Res."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Hojnik, M., Kenda Suster, N., Smrkolj, S., Frkovic Grazio, S., Verdenik, I., and Rizner, T.L. (2020). AKR1C3 Is Associated with Better Survival of Patients with Endometrial Carcinomas. J. Clin. Med., 9.","DOI":"10.3390\/jcm9124105"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1124\/mol.118.111674","article-title":"RGS10 Regulates the Expression of Cyclooxygenase-2 and Tumor Necrosis Factor Alpha through a G Protein-Independent Mechanism","volume":"94","author":"Alqinyah","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/med.21389","article-title":"COX-1 Inhibitors: Beyond Structure Toward Therapy","volume":"36","author":"Vitale","year":"2016","journal-title":"Med. Res. Rev."},{"key":"ref_99","first-page":"2254","article-title":"Prostaglandin D2 expression is prognostic in highgrade serous ovarian cancer","volume":"41","author":"Alves","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3892\/ol.2015.2884","article-title":"Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review)","volume":"9","author":"Fernandes","year":"2015","journal-title":"Oncol. Lett."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Frejborg, E., Salo, T., and Salem, A. (2020). Role of Cyclooxygenase-2 in Head and Neck Tumorigenesis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239246"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/15384047.2015.1071741","article-title":"Expression and clinical implication of cyclooxygenase-2 and E-cadherin in oral squamous cell carcinomas","volume":"21","author":"Santoro","year":"2020","journal-title":"Cancer Biol. Ther."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1080\/15384047.2015.1040953","article-title":"Molecular inhibition of prostaglandin E2 with GW627368X: Therapeutic potential and preclinical safety assessment in mouse sarcoma model","volume":"16","author":"Parida","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12967-015-0413-4","article-title":"Diacetyloxyl derivatization of the fibroblast growth factor inhibitor dobesilate enhances its anti-inflammatory, anti-angiogenic and anti-tumoral activities","volume":"13","author":"Angulo","year":"2015","journal-title":"J. Transl. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-3-030-50224-9_6","article-title":"COX-2 Signaling in the Tumor Microenvironment","volume":"1277","author":"Zhang","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10753-015-0247-5","article-title":"3,5-Disubstituted Isoxazole Derivatives: Potential Inhibitors of Inflammation and Cancer","volume":"39","author":"Rakesh","year":"2016","journal-title":"Inflammation"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"617211","DOI":"10.3389\/fphar.2020.617211","article-title":"Extracellular ATP Mediates Cancer Cell Migration and Invasion through Increased Expression of Cyclooxygenase 2","volume":"11","author":"Sharma","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.apsb.2018.09.002","article-title":"Repurposing vitamin D for treatment of human malignancies via targeting tumor microenvironment","volume":"9","author":"Wu","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Almeida, E.B., Silva, K.P.H., Paixao, V., Amaral, J.B.D., Rossi, M., Xavier-Navarro, R.A., Barros, K.V., Silveira, V.L.F., Vieira, R.P., and Oliveira, L.V.F. (2019). A Mixture of Polyunsaturated Fatty Acids omega-3 and omega-6 Reduces Melanoma Growth by Inhibiting Inflammatory Mediators in the Murine Tumor Microenvironment. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153765"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1586\/ecp.10.120","article-title":"Defining the COX inhibitor selectivity of NSAIDs: Implications for understanding toxicity","volume":"3","author":"Knights","year":"2010","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"110389","DOI":"10.1016\/j.biopha.2020.110389","article-title":"Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement","volume":"129","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5483\/BMBRep.2020.53.4.164","article-title":"15d-PGJ2 inhibits NF-\u03baB and AP-1-mediated MMP-9 expression and invasion of breast cancer cell by means of a heme oxygenase-1-dependent mechanism","volume":"53","author":"Jang","year":"2020","journal-title":"BMB Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"109581","DOI":"10.1016\/j.biopha.2019.109581","article-title":"Microsomal prostaglandin E synthase-1 promotes lung metastasis via SDF-1\/CXCR4-mediated recruitment of CD11b(+)Gr1(+)MDSCs from bone marrow","volume":"121","author":"Takahashi","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"9842","DOI":"10.1074\/jbc.M114.602185","article-title":"Roles of the cyclooxygenase 2 matrix metalloproteinase 1 pathway in brain metastasis of breast cancer","volume":"290","author":"Wu","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10555-018-9755-8","article-title":"Bioactive lipid metabolism in platelet \u201cfirst responder\u201d and cancer biology","volume":"37","author":"Kopetz","year":"2018","journal-title":"Cancer Metastasis Rev."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbi.2016.05.017","article-title":"Reducing liver metastases of colon cancer in the context of extensive and minor surgeries through \u03b2-adrenoceptors blockade and COX2 inhibition","volume":"58","author":"Sorski","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s00432-020-03272-0","article-title":"Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR)","volume":"146","author":"Ye","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1158\/0008-5472.CAN-19-2843","article-title":"Tumor-Derived Prostaglandin E2 Promotes p50 NF-\u03baB-Dependent Differentiation of Monocytic MDSCs","volume":"80","author":"Porta","year":"2020","journal-title":"Cancer Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e000889","DOI":"10.1136\/jitc-2020-000889","article-title":"Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer","volume":"8","author":"Wang","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1172\/JCI127755","article-title":"Tumor cell-intrinsic EPHA2 suppresses anti-tumor immunity by regulating PTGS2 (COX-2)","volume":"129","author":"Markosyan","year":"2019","journal-title":"J. Clin. Invest."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-019-1118-2","article-title":"Fatty acid transport protein 2 reprograms neutrophils in cancer","volume":"569","author":"Veglia","year":"2019","journal-title":"Nature"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-020-2166-3","article-title":"Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche","volume":"580","author":"Roulis","year":"2020","journal-title":"Nature"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/6\/1487\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:13:50Z","timestamp":1760163230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/6\/1487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,13]]},"references-count":122,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["cells10061487"],"URL":"https:\/\/doi.org\/10.3390\/cells10061487","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,13]]}}}